(Q73846700)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Immune tolerance mediated by recombinant proteolipid protein prevents experimental autoimmune encephalomyelitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

experimental autoimmune encephalomyelitis

7 November 2019

main subject

0 references

author name string

E A Elliott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

R Cofiell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J A Wilkins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C S Raine

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L A Matis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J P Mueller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Induction of TH1 and TH2 immunity in neonatal mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Expression of myelin proteins in the developing human spinal cord: cloning and sequencing of human proteolipid protein cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Purification of immunologically active recombinant 21.5 kDa isoform of human myelin basic protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Intravenous antigen administration as a therapy for autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Minireview: autoimmune responses to myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Use of T7 RNA polymerase to direct expression of cloned genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Myelin proteolipid protein induces demyelinating disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Self-determinants in autoimmune demyelinating disease: changes in T- cell response specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Immune processing of proteolipid protein by subsets of antigen-presenting spleen cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900093-3

7 January 2021

10.1016/S0165-5728(97)00093-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9357441%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference